🤖 IA: It's clickbait ⚠️
👥 Users: It's clickbait ⚠️
#bonehealth #coffeeconsumption #studyfindings
👇👇👇
🤖 IA: It's clickbait ⚠️
👥 Users: It's clickbait ⚠️
#bonehealth #coffeeconsumption #studyfindings
👇👇👇
https://studytactics.help/gen-z-exposes-study-work-from-home-productivity-li/?utm_source=bluesky&utm_medium=social
#genzproductivity #remoteworkpolicies #studyfindings
https://studytactics.help/gen-z-exposes-study-work-from-home-productivity-li/?utm_source=bluesky&utm_medium=social
#genzproductivity #remoteworkpolicies #studyfindings
yespunjab.com?p=82151
#ReelAddiction #HighBloodPressure #StudyFindings #MentalHealth #YoungAdults #MiddleAgedHealth #BPStudy #AddictionEffects #HealthAwareness #BloodPressure
yespunjab.com?p=82151
#ReelAddiction #HighBloodPressure #StudyFindings #MentalHealth #YoungAdults #MiddleAgedHealth #BPStudy #AddictionEffects #HealthAwareness #BloodPressure
- Out of 6.1M, 37,189 received ranibizumab, 39,447 aflibercept, & 163,611 bevacizumab.
- Incidence of kidney failure was 678 per 100,000 persons.
- No significant difference in kidney failure risk among the treatments. #studyfindings
- Out of 6.1M, 37,189 received ranibizumab, 39,447 aflibercept, & 163,611 bevacizumab.
- Incidence of kidney failure was 678 per 100,000 persons.
- No significant difference in kidney failure risk among the treatments. #studyfindings